"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"Pacira Pharmaceuticals, Inc.","Pacira BioSciences","$3,500,000","$3,500,000","$0","2020","20200729","competition-related offenses","kickbacks and bribery","","Pacira agreed to pay $3.5 million to settlement litigation brought by the United States and 15 states alleging it paid kickbacks in the form of research grants to increase sales of its product Exparel. The settlement was also announced by the Justice Department (see separate entry).","state","agency action","Multistate Attorneys General Case","civil","","","","","","","","","","","","USA","New Jersey","publicly traded","PCRX","pharmaceuticals","non-opioid pain management","https://ncdoj.gov/attorney-general-josh-stein-reaches-settlement-over-pharma-company-kickback-allegations/",""
"Pacira Pharmaceuticals Inc.","Pacira BioSciences","$3,500,000","$0","$3,500,000","2020","20200728","government-contracting-related offenses","False Claims Act and related","kickbacks and bribery","","federal","agency action","U.S. Attorney-District of New Jersey","civil","","","","","","","","","","","","USA","New Jersey","publicly traded","PCRX","pharmaceuticals","non-opioid pain management","https://www.justice.gov/usao-nj/pr/pharmaceutical-company-agrees-pay-35-million-resolve-allegations-violating-false-claims",""
